Page 18 - Read Online

Al-Khyatt et al. Mini-invasive Surg 2018;2:3 I http://dx.doi.org/10.20517/2574-1225.2017.49 Page 5 of 5

Patient consent
Not applicable.

Ethics approval
Not applicable.

Copyright
© The Author(s) 2018.

REFERENCES
1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The montreal definition and classification of gastroesophageal reflux disease: a global
evidence-based consensus. Am J Gastroenterol 2006;101:1900-20.
2. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut
2005;54:710-7.
3. El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut
2014;63:871-80.
4. El-Serag H. Role of obesity in GORD-related disorders. Gut 2008;57:281-4.
5. Lagergren J. Influence of obesity on the risk of esophageal disorders. Nat Rev Gastroenterol Hepatol 2011;8:340-7.
6. El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J
Gastroenterol 2005;100:1243-50.
7. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Risk factors associated with symptoms of gastroesophageal reflux. Am J
Med 1999;106:642-9.
8. Murray L, Johnston B, Lane A, Harvey I, Donovan J, Nair P, Harvey R. Relationship between body mass and gastro-oesophageal reflux
symptoms: The Bristol Helicobacter Project. Int J Epidemiol 2003;32:645-50.
9. Ruhl CE, Everhart JE. Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the
NHANES I Epidemiologic Followup Study. First National Health and Nutrition Examination Survey. Ann Epidemiol 1999;9:424-35.
10. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann
Intern Med 2005;143:199-211.
11. Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol
2006;101:2619-28.
12. Crowell MD, Bradley A, Hansel S, Dionisio P, Kim HJ, Decker GA, DiBaise JK, Sharma VK. Obesity is associated with increased 48-h
esophageal acid exposure in patients with symptomatic gastroesophageal reflux. Am J Gastroenterol 2009;104:553-9.
13. Singh S, Sharma AN, Murad MH, Buttar NS, El-Serag HB, Katzka DA, Iyer PG. Central adiposity is associated with increased risk
of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol
2013;11:1399-412.e7.
14. Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ. Obesity: a challenge to esophagogastric junction integrity.
Gastroenterology 2006;130:639-49.
15. El-Serag HB, Ergun GA, Pandolfino J, Fitzgerald S, Tran T, Kramer JR. Obesity increases oesophageal acid exposure. Gut 2007;56:749-55.
16. Schneider JE, Brücher BDM, Küper M, Saemann K, Königsrainer A, Schneider J. Multichannel intraluminal impedance measurement of
gastroesophageal reflux in patients with different stages of morbid obesity. Obes Surg 2009;19:1522-9.
17. Telem DA, Altieri M, Gracia G, Pryor AD. Perioperative outcome of esophageal fundoplication for gastroesophageal reflux disease in obese
and morbidly obese patients. Am J Surg 2014;208:163-8.
18. Morgenthal C, Lin E, Shane M, Hunter J, Smith CD. Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of long-
term outcomes. Surg Endosc 2007;21:1978-84.
19. Perez AR, Moncure AC, Rattner DW. Obesity adversely affects the outcome of antireflux operations. Surg Endosc 2001;15:986-9.
20. Ng VV, Booth MI, Stratford JJ, Jones L, Sohanpal J, Dehn TC. Laparoscopic anti-reflux surgery is effective in obese patients with gastro-
oesophageal reflux disease. Ann R Coll Surg Engl 2007;89:696-702.
21. Anvari M, Bamehriz F. Outcome of laparoscopic Nissen fundoplication in patients with body mass index ≥ 35. Surg Endosc 2006;20:230-4.
22. D’Alessio MJ, Arnaoutakis D, Giarelli N, Villadolid DV, Rosemurgy AS. Obesity is not a contraindication to laparoscopic Nissen
fundoplication. J Gastrointest Surg 2005;9:949-54.
23. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R, Global Consensus G. The Montreal definition and classification of gastroesophageal
reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20; quiz 43.
24. Dallemagne B, Perretta S. Twenty years of laparoscopic fundoplication for GERD. World J Surg 2011;35:1428-35.
25. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol
2013;108:308-28.
26. Stefanidis D, Hope WW, Kohn GP, Reardon PR, Richardson WS, Fanelli RD. Guidelines for surgical treatment of gastroesophageal reflux
disease. Surg Endosc 2010;24:2647-69.
27. Pagé MP, Kastenmeier A, Goldblatt M, Frelich M, Bosler M, Wallace J, Gould J. Medically refractory gastroesophageal reflux disease in the
obese: what is the best surgical approach? Surg Endosc 2014;28:1500-4.
28. Morgenthal CB, Lin E, Shane MD, Hunter JG, Smith CD. Who will fail laparoscopic Nissen fundoplication? Preoperative prediction of
long-term outcomes. Surg Endosc 2007;21:1978-84.
29. Pallati PK, Shaligram A, Shostrom VK, Oleynikov D, McBride CL, Goede MR. Improvement in gastroesophageal reflux disease symptoms
after various bariatric procedures: review of the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis 2014;10:502-7.